Literature DB >> 26997089

Portal Vein Recanalization and Transjugular Intrahepatic Portosystemic Shunt Creation for Chronic Portal Vein Thrombosis: Technical Considerations.

Bartley Thornburg1, Kush Desai1, Ryan Hickey1, Laura Kulik2, Daniel Ganger2, Talia Baker3, Michael Abecassis3, Robert J Lewandowski1, Riad Salem4.   

Abstract

Portal vein thrombosis (PVT) is common in cirrhotic patients and presents a challenge at the time of transplant. Owing to the increased posttransplant morbidity and mortality associated with complete PVT, the presence of PVT is a relative contraindication to liver transplantation at many centers. Our group began performing portal vein (PV) recanalization and transjugular intrahepatic portostystemic shunt placement (PVR-TIPS) several years ago to optimize the transplant candidacy of patients with PVT. The procedure has evolved to include transsplenic access to assist with recanalization, which is now our preferred method due to its technical success without significant added morbidity. Here, we describe in detail our approach to PVR-TIPS with a focus on the transsplenic method. The procedure was attempted in 61 patients and was technically successful in 60 patients (98%). After transitioning to transsplenic access to assist with recanalization, the technical success rate has improved to 100%. The recanalized portal vein and TIPS have maintained patency during follow-up, or to the time of transplant, in 55 patients (92%) with a mean follow-up of 16.7 months. In total, 23 patients (38%) have undergone transplant, all of whom received a physiologic anastomosis (end-to-end anastomosis in 22 of 23 patients, 96%). PVR-TIPS placement should be considered as an option for patients with chronic PVT in need of transplantation. Transsplenic access makes the procedure technically straightforward and should be considered as the primary method for recanalization.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Portal vein thrombosis; TIPS; liver transplantation

Mesh:

Year:  2016        PMID: 26997089     DOI: 10.1053/j.tvir.2016.01.006

Source DB:  PubMed          Journal:  Tech Vasc Interv Radiol        ISSN: 1557-9808


  16 in total

Review 1.  Management of Non-tumoral Portal Vein Thrombosis in Patients with Cirrhosis.

Authors:  Jonathan G Stine; Patrick G Northup
Journal:  Dig Dis Sci       Date:  2019-03       Impact factor: 3.199

2.  Timing of Anticoagulation for Portal Vein Thrombosis in Liver Cirrhosis: A US Hepatologist's Perspective.

Authors:  Patrick G Northup; Jessica P E Davis
Journal:  J Transl Int Med       Date:  2018-03-28

Review 3.  Imaging-guided interventions modulating portal venous flow: Evidence and controversies.

Authors:  Roberto Cannella; Lambros Tselikas; Fréderic Douane; François Cauchy; Pierre-Emmanuel Rautou; Rafael Duran; Maxime Ronot
Journal:  JHEP Rep       Date:  2022-04-04

Review 4.  Where does TIPS fit in the management of patients with cirrhosis?

Authors:  Juan Carlos García-Pagán; Saad Saffo; Mattias Mandorfer; Guadalupe Garcia-Tsao
Journal:  JHEP Rep       Date:  2020-05-23

Review 5.  New Techniques and Devices in Transjugular Intrahepatic Portosystemic Shunt Placement.

Authors:  Jamie RiChard; Bartley Thornburg
Journal:  Semin Intervent Radiol       Date:  2018-08-06       Impact factor: 1.513

6.  TIPS performed in a patient with complete portal vein thrombosis.

Authors:  Ashwani Kumar Sharma; David Charles Kaufman
Journal:  Radiol Case Rep       Date:  2017-02-20

7.  Concepts and Controversies in Haemostasis and Thrombosis Associated with Liver Disease: Proceedings of the 7th International Coagulation in Liver Disease Conference.

Authors:  N M Intagliata; C K Argo; J G Stine; T Lisman; S H Caldwell; F Violi
Journal:  Thromb Haemost       Date:  2018-07-30       Impact factor: 5.249

8.  Hypercoagulability in End-stage Liver Disease: Review of Epidemiology, Etiology, and Management.

Authors:  Thomas A Verbeek; Jonathan G Stine; Fuat H Saner; Dmitri Bezinover
Journal:  Transplant Direct       Date:  2018-10-26

9.  Transjugular intrahepatic portosystemic shunt assisted with trans-splenic access.

Authors:  Zhang Cheng; Feng Wang; Jianfei Liu
Journal:  Clin Mol Hepatol       Date:  2019-06-19

10.  Ex Vivo Cell Therapy by Ectopic Hepatocyte Transplantation Treats the Porcine Tyrosinemia Model of Acute Liver Failure.

Authors:  Clara T Nicolas; Robert A Kaiser; Raymond D Hickey; Kari L Allen; Zeji Du; Caitlin J VanLith; Rebekah M Guthman; Bruce Amiot; Lukkana Suksanpaisan; Bing Han; Maria Giovanna Francipane; Amin Cheikhi; Huailei Jiang; Aditya Bansal; Mukesh K Pandey; Ishan Garg; Val Lowe; Aditya Bhagwate; Daniel O'Brien; Jean-Pierre A Kocher; Timothy R DeGrado; Scott L Nyberg; Eric Lagasse; Joseph B Lillegard
Journal:  Mol Ther Methods Clin Dev       Date:  2020-07-10       Impact factor: 6.698

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.